80 FR 57002 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Animal Food Labeling; Declaration of Certifiable Color Additives

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 80, Issue 182 (September 21, 2015)

Page Range		57002-57002
FR Document		2015-23566

The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Animal Food Labeling; Declaration of Certifiable Color Additives'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

Federal Register, Volume 80 Issue 182 (Monday, September 21, 2015)

[Federal Register Volume 80, Number 182 (Monday, September 21, 2015)]
[Notices]
[Page 57002]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-23566]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0025]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Animal Food Labeling; Declaration of 
Certifiable Color Additives

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Animal Food Labeling; Declaration 
of Certifiable Color Additives'' has been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, 
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver 
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: On July 16, 2015, the Agency submitted a 
proposed collection of information entitled ``Animal Food Labeling; 
Declaration of Certifiable Color Additives'' to OMB for review and 
clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, 
and a person is not required to respond to, a collection of information 
unless it displays a currently valid OMB control number. OMB has now 
approved the information collection and has assigned OMB control number 
0910-0721. The approval expires on August 31, 2018. A copy of the 
supporting statement for this information collection is available on 
the Internet at http://www.reginfo.gov/public/do/PRAMain.

    Dated: September 11, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-23566 Filed 9-18-15; 8:45 am]
BILLING CODE 4164-01-P

57002 Federal Register / Vol. 80, No. 182 / Monday, September 21, 2015 / Notices

Identify comments with the docket OMB control number 0910–0721. The Representative nominations may be
number found in brackets in the approval expires on August 31, 2018. A submitted electronically by accessing
heading of this document. The copy of the supporting statement for this the FDA Advisory Committee
guidances, notices, and received information collection is available on Membership Nomination Portal: https://
comments may be seen in the Division the Internet at http://www.reginfo.gov/ www.accessdata.fda.gov/scripts/
of Dockets Management between 9 a.m. public/do/PRAMain. FACTRSPortal/FACTRS/index.cfm, by
and 4 p.m., Monday through Friday, and Dated: September 11, 2015. mail to Advisory Committee Oversight
will be posted to the docket at http:// Leslie Kux,
and Management Staff, Food and Drug
www.regulations.gov. Administration, 10903 New Hampshire
Associate Commissioner for Policy.
Ave., Bldg. 32, Rm. 5103, Silver Spring,
V. Electronic Access [FR Doc. 2015–23566 Filed 9–18–15; 8:45 am]
MD 20993–0002, or FAX: 301–847–
Persons with access to the Internet BILLING CODE 4164–01–P 8640. Information about becoming a
may obtain the document at either member of an FDA advisory committee
http://www.fda.gov/Drugs/ can also be obtained by visiting FDA’s
GuidanceCompliance DEPARTMENT OF HEALTH AND
Web site at
RegulatoryInformation/Guidances/ HUMAN SERVICES
http://www.fda.gov/
default.htm or http:// AdvisoryCommittees/default.htm.
Food and Drug Administration
www.regulations.gov. FOR FURTHER INFORMATION CONTACT: For
[Docket No. FDA–2015–N–3224]
Dated: September 15, 2015. questions relating to participation in the
Leslie Kux, Request for Nominations of Individuals selection process: Kimberly Hamilton,
Associate Commissioner for Policy. and Consumer Organizations for the Advisory Committee Oversight and
[FR Doc. 2015–23571 Filed 9–18–15; 8:45 am] Patient Engagement Advisory Management Staff, Food and Drug
BILLING CODE 4164–01–P Committee Administration, 10903 New Hampshire
Ave., Bldg. 32, Rm. 5117, Silver Spring,
AGENCY: Food and Drug Administration, MD 20993–0002, 301–796–6319,
DEPARTMENT OF HEALTH AND HHS. kimberly.hamilton@fda.hhs.gov.
HUMAN SERVICES ACTION: Notice. For questions relating to the
Committee: Letise Williams, Center for
Food and Drug Administration SUMMARY: The Food and Drug Devices and Radiological Health, Food
Administration (FDA) is requesting that and Drug Administration, 10903 New
[Docket No. FDA–2009–N–0025] any consumer organizations interested Hampshire Ave., Bldg. 66, Rm. 5441,
in participating in the selection of a Silver Spring, MD 20993–0002, 301–
Agency Information Collection
voting consumer representative to serve 796–8398, letise.williams@fda.hhs.gov.
Activities; Announcement of Office of
on the Patient Engagement Advisory SUPPLEMENTARY INFORMATION: FDA is
Management and Budget Approval;
Committee (the Committee) notify FDA requesting nominations for a voting
Animal Food Labeling; Declaration of
in writing. FDA is also requesting consumer representative on the
Certifiable Color Additives
nominations for a voting consumer Committee.
AGENCY: Food and Drug Administration, representative to serve on the Elsewhere in this issue of the Federal
HHS. Committee. Nominees recommended to Register, FDA is publishing separate
ACTION: Notice. serve as a voting consumer documents regarding:
representative may either be self- 1. Patient Engagement Advisory
SUMMARY: The Food and Drug nominated or may be nominated by a
Administration (FDA) is announcing Committee; Notice of Establishment.
consumer organization. Nominations 2. Request for Nominations for Voting
that a collection of information entitled will be accepted for the current vacancy
‘‘Animal Food Labeling; Declaration of Members for the Patient Engagement
effective with this notice. Advisory Committee.
Certifiable Color Additives’’ has been FDA seeks to include the views of
approved by the Office of Management 3. Request for Nominations of
women and men, members of all racial Individuals and Industry Organizations
and Budget (OMB) under the Paperwork and ethnic groups, and individuals with
Reduction Act of 1995. for the Patient Engagement Advisory
and without disabilities on its advisory Committee.
FOR FURTHER INFORMATION CONTACT: FDA committees and, therefore encourages
PRA Staff, Office of Operations, Food nominations of appropriately qualified I. General Description of the
and Drug Administration, 8455 candidates from these groups. Committee’s Duties
Colesville Rd., COLE–14526, Silver DATES: Any consumer organization The Committee provides advice on
Spring, MD 20993–0002, PRAStaff@ interested in participating in the complex issues relating to medical
fda.hhs.gov. selection of an appropriate voting devices, the regulation of devices, and
SUPPLEMENTARY INFORMATION: On July member to represent consumer interests their use by patients. Agency guidance
16, 2015, the Agency submitted a on the Committee may send a letter or and policies, clinical trial or registry
proposed collection of information email stating that interest to FDA by design, patient preference study design,
entitled ‘‘Animal Food Labeling; October 21, 2015. Concurrently, benefit-risk determinations, device
Declaration of Certifiable Color nomination materials for prospective labeling, unmet clinical needs, available
Additives’’ to OMB for review and candidates should be sent to FDA by alternatives, patient reported outcomes
rmajette on DSK7SPTVN1PROD with NOTICES

clearance under 44 U.S.C. 3507. An October 21, 2015. and device-related quality of life or
Agency may not conduct or sponsor, ADDRESSES: All statements of interest health status issues are among the topics
and a person is not required to respond from consumer organizations interested that may be considered by the
to, a collection of information unless it in participating in the selection process Committee. Members are knowledgeable
displays a currently valid OMB control should be sent electronically to in areas such as clinical research,
number. OMB has now approved the Kimberly Hamilton (see FOR FURTHER primary care patient experience, health
information collection and has assigned INFORMATION CONTACT). All Consumer care needs of patient groups in the

VerDate Sep<11>2014 15:14 Sep 18, 2015 Jkt 235001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\21SEN1.SGM 21SEN1

Document Created: 2015-12-15 09:39:07
Document Modified: 2015-12-15 09:39:07

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Contact		FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver Spring, MD 20993-0002, [email protected]
FR Citation		80 FR 57002

80 FR 57002 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Animal Food Labeling; Declaration of Certifiable Color Additives

DEPARTMENT OF HEALTH AND HUMAN SERVICESFood and Drug Administration

Federal Register Volume 80, Issue 182 (September 21, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration